OpenBio News

[OpenBio News @openbionews]

https://t.co/UGHKE3zrAt

[OpenBio News @openbionews]

🧬 Daily Bio (7/18):
🚀 Biotech IPO wave continues (Braveheart, Attovia, Vogenx)
💊 FDA approves 1st oral PCSK9 (Merck's Lipfendra)
✅ Novartis gets full Fabhalta approval (IgAN)
🤝 Lilly buys AtaiBeckley for $2.8B

🔗 https://t.co/iy4ZGz1BhC
#Biotech #Pharma

[OpenBio News @openbionews]

🧬 Daily Bio (7/17):
📉 GSK drops $2B Bellus cough drug
✅ Celcuity gets FDA breast cancer nod
💊 Lilly buys AtaiBeckley for $2.8B
📈 IPO filings heat up

🔗 https://t.co/PwEdiTfWLo
#Biotech #Pharma

[OpenBio News @openbionews]

🧬 Biotech Movers (7/16):
🚀 $ATAI +33% (Lilly $3.8B buyout)
🚀 $CDNA +36% (Naveris close + divestiture)
🚀 $JSPR +12% (Kira merger + $132M PIPE)
📉 $MODD -23%, $SNTI -21%, $KALA -18% (Dilution overhang)

Read more: https://t.co/FBfaPNGkBj
#Biotech #Stocks

[OpenBio News @openbionews]

🧬 Daily Bio (7/16):
💊 Merck wins 1st FDA approval for oral PCSK9
🧠 Lilly buys AtaiBeckley for ~$3B in psychedelics push
📉 H1 '26 biopharma layoffs projected >14,000
⚖️ Sanofi sues Pfizer & Moderna over mRNA patents

Read more: https://t.co/ildwwx8qeP
#Biotech #Pharma

[OpenBio News @openbionews]

🧬 Daily Bio (7/15):
🎯 Kelun-Merck ADC wins NSCLC
📈 H1 '26 Biotech IPOs double
🏛️ FDA resumes CRL releases
🔗 https://t.co/XCQ8oVMF6T
#Biotech #Pharma

[OpenBio News @openbionews]

Happy 4th of July! 🎆 Before the fireworks, catch up on today's top biopharma news.

Clinical data, FDA moves, and deal flow—distilled in 2 minutes.

Read the July 4 summary 👇
https://t.co/PakGl6LUwV

#Biopharma #Biotech

[OpenBio News @openbionews]

30 seconds to catch up on June 30’s biopharma news. 📰

Clinical data, FDA moves, and M&A deals—distilled.

Don’t scroll, just read the summary 👇 https://t.co/Fgf7qJ3tjX

#Biopharma #Biotech

[OpenBio News @openbionews]

Biotech hiring isn’t frozen—it’s realigning. 📊

June 2026 data shows a surge in:
🧬 AI-Bio hybrid roles
🏥 Clinical & Regulatory ops
🏭 Domestic manufacturing
The "generalist" squeeze is real. Specialization wins.
Full hiring analysis👇
https://t.co/XReMN8bNot
#Biotech #Jobs

[OpenBio News @openbionews]

The FDA just picked 7 winners out of 80+ applicants for its new PreCheck Pilot to boost US drug manufacturing. 🏭

Lilly, Regeneron, and top CDMOs made the cut. But the omissions are telling.

See the full list & breakdown 👇 https://t.co/O8dWWzrUy1

#FDA #Biopharma

[OpenBio News @openbionews]

H2 2026 is make-or-break for biopharma. 🗓️

Critical PDUFA dates, Phase 3 readouts & major medical conferences are packed into the next 6 months.

Which catalysts will spark the next big M&A wave? 📈

Full H2 cheat sheet 👇 https://t.co/1P04AUY47e

#Biotech #Biopharma

[OpenBio News @openbionews]

Out of 330+ AI-bio startups, only 10 matter in 2026. 🧬🤖

The hype is over. Clinical proof is here:
🤝 M&A wave ($RXRX, PathAI)
💊 AI molecules in Ph 2/3 trials
💰 Insilico hits $3.5B+ in deals

See the Top 10 👇 https://t.co/6roaGBD5sm

#AIBio #TechBio #DrugDiscovery

[OpenBio News @openbionews]

June 27 Biopharma Recap 🧬👇

🏛️ FDA okays Viridian eye drug (rivaling $AMGN)
🤝 $PFE inks $10B China pact; GSK makes major buyout
⚖️ Bayer wins big at Supreme Court
🦠 Congo Ebola hits 1k cases

Full summary 👇 https://t.co/ZbDWKOBe0k

#Biotech #Pharma #LifeSciences

[OpenBio News @openbionews]

Biotech defied the market Friday! 📈 Massive single-stock moves dominated the tape:
🚀 $CRIS +56%
🚀 $TECH +20%
🚀 $KYMR +16%
📉 $TVRD, $SPRY, $PASG down 24-36%

It’s a stock-picker's market. Full daily breakdown 👇 https://t.co/EdCaC2sUrU

#Biotech #FinTwit